CompanyGraph
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleMarket cap is $3.55B, above the global median of $1.15B
- FinancialsAltman Z-Score 1.2: grey zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.59%
Annual Rate
USD 0.08Paid quarterly
Payout Ratio
8.6%Sustainable
Paying Dividends
6 yr
Last Ex-Dividend
May 11, 2026
Last Payment
Jun 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.55BUSDvs all stocks (USD)
Trailing P/E
14.54xRevenue (TTM)
6.16BUSDvs all stocks (USD)
Profit Margin
3.99%Beta
1.54xvs all stocks
52-Week Change
43.07%vs all stocks
Forward Annual Dividend Yield
0.59%vs all stocks
Market Capitalization
3.55BUSDvs all stocks (USD)
Enterprise Value
11.00BUSDvs all stocks (USD)
Trailing P/E
14.54xForward P/E
3.72xPEG Ratio
0.2247xPrice to Sales (TTM)
0.5761xPrice to Book (MRQ)
3.93xEnterprise to Revenue
1.78xEnterprise to EBITDA
6.90xGross Margin
53.63%Profit Margin
3.99%Operating Margin
18.70%Return on Assets (TTM)
5.89%Return on Equity (TTM)
34.05%Revenue (TTM)
6.16BUSDvs all stocks (USD)
Revenue per Share (TTM)
23.69USDUpdated Jul 19, 2026Quarterly Revenue Growth
-3.50%Gross Profit (TTM)
3.32BUSDvs all stocks (USD)
EBITDA (TTM)
1.76BUSDvs all stocks (USD)
Net Income (TTM)
246.00MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
67.80%Operating Cash Flow (TTM)
850.00MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
529.12MUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.0800USDUpdated Jul 19, 2026Forward Annual Dividend Yield
0.59%vs all stocks
Trailing Annual Dividend Rate
0.0800USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.59%vs all stocks
Payout Ratio
8.60%Revenue
6.22BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
2.90BUSDFY2025 · Dec 31, 2025Gross Profit
3.31BUSDFY2025 · Dec 31, 2025Operating Income
1.23BUSDvs all stocks (USD)
Pre-tax Income
425.00MUSDFY2025 · Dec 31, 2025Income Tax Expense
238.00MUSDFY2025 · Dec 31, 2025Net Income
187.00MUSDFY2025 · Dec 31, 2025EBIT
929.00MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.71BUSDFY2025 · Dec 31, 2025Research & Development
366.00MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
1.72BUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
504.00MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.7200USDFY2025 · Dec 31, 2025EPS (Diluted)
0.7200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
259.50MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
259.50MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
187.00MUSDFY2025 · Dec 31, 2025Operating Cash Flow
687.00MUSDFY2025 · Dec 31, 2025Free Cash Flow
686.00MUSDDerived from operating cash flow minus capital expenditure. This filing charges 361M of depreciation against 1M of capital expenditure, and its own free-cash-flow line reads 384M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
574.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
187.00MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
361.00MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
63.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
77.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
43.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
79.00MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-217.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
94.00MUSDFY2025 · Dec 31, 2025Capital Expenditures
1.00MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-154.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
-75.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-74.00MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.05BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.51BUSDFY2025 · Dec 31, 2025Common Dividends Paid
-88.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-15.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-561.00MUSDFY2025 · Dec 31, 2025Shares Outstanding
262.65MSharesUpdated Jul 19, 2026Float Shares
261.08MSharesUpdated Jul 19, 2026Shares Short
17.09MSharesUpdated Jul 19, 2026Short Ratio
7.00daysvs all stocks
Short % of Shares Outstanding
7.40%vs all stocks
% Held by Insiders
0.47%vs all stocks
% Held by Institutions
77.85%vs all stocks
Total Cash (MRQ)
1.12BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
4.25USDUpdated Jul 19, 2026Total Debt (MRQ)
8.57BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
9.49xCurrent Ratio (MRQ)
1.97xBook Value per Share (MRQ)
3.44USDUpdated Jul 19, 2026Total Assets
12.87BUSDvs all stocks (USD)
Total Current Assets
4.35BUSDFY2025 · Dec 31, 2025Total Liabilities
12.12BUSDFY2025 · Dec 31, 2025Total Non-current Assets
8.52BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
9.72BUSDFY2025 · Dec 31, 2025Total Current Liabilities
2.39BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
574.00MUSDFY2025 · Dec 31, 2025Accounts Receivable
1.33BUSDFY2025 · Dec 31, 2025Inventory
1.41BUSDFY2025 · Dec 31, 2025Accounts Payable
952.00MUSDFY2025 · Dec 31, 2025Short-term Debt
16.00MUSDFY2025 · Dec 31, 2025Other Current Liabilities
2.00MUSDFY2025 · Dec 31, 2025Long-term Debt
8.63BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
1.01BUSDFY2025 · Dec 31, 2025Common Stock (Book)
3.00MUSDFY2025 · Dec 31, 2025Retained Earnings
1.11BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
752.00MUSDvs all stocks (USD)
52-Week Low
5.69USDUpdated Jul 19, 202652-Week High
13.60USDUpdated Jul 19, 202652-Week Change
43.07%vs all stocks
Beta
1.54xvs all stocks
50-Day MA
13.43USDUpdated Jul 19, 2026200-Day MA
9.39USDUpdated Jul 19, 2026Avg 10-Day Volume
2.57MSharesUpdated Jul 19, 2026Avg 30-Day Volume
2.41MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
0.9300USDUpdated Jul 19, 2026Other Income / Expense
-297.00MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Debt Financing Activity
More cash moved through borrowing and repaying than through the business itself, and most of its debt is long-term.
Reads
How is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.54Profit Margin: 0.04
Financial Health
Altman Z-Score 1.2: grey zoneSignificant
Altman Z-Score: 1.20
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $3.55B, above the global median of $1.15BNotable
Market cap (USD): 3,550,479,534Global Median: 1,146,734,693.424
Revenue is $6.16B, above the global median of $520.53MNotable
Revenue (USD): 6,162,999,808Global Median: 520,528,949.311
Levered free cash flow is $529.12M, above the global median of $16.24MNotable
Levered free cash flow (USD): 529,124,992Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Hualan Biological Engineering Inc.
Tier 1ProductionApproval-Gated PipelineRule
Haemonetics Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Arcutis Biotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pegbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Laboratorios Farmacéuticos Rovi SA
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hanmi Pharm Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alumis Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Ideaya Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Irhythm Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Huadian Liaoning Energy Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone
Gannett Co., Inc.
1 interpretationWithin or Near the Altman Distress Zone
Xinjiang Lixin Energy Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone